Avrobio Inc reported $-29833000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Akebia Therapeutics AKBA:US USD -7552000 44.31M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Bluebird Bio BLUE:US USD -76513000 16.99M
Gilead Sciences GILD:US USD 2.52B 357M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Karyopharm Therapeutics KPTI:US USD -38433000 2.15M
Macrogenics MGNX:US USD 12.8M 37.61M
Pfizer PFE:US USD 7.38B 3.3B
Roche Holding ROG:VX 8.85B 3.26B
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Sanofi SAN:FP EUR 2.75B 1.68B
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
Takeda 4502:JP JPY 107.15B 42.6B